QMSR
Quality Management System Regulation
QMSR (Quality Management System Regulation) is 미국 의료기기 품질 요구사항을 ISO 13485와 일치시키고 현재의 품질 시스템 규정(QSR)을 대체할 FDA의 제안된 품질 관리 시스템 규정.
Complete Guide to QMSR
The Quality Management System Regulation (QMSR) is the FDA's proposed modernization of medical device quality requirements that will align US regulations with the international standard ISO 13485:2016. Once finalized, QMSR will replace the current Quality System Regulation (21 CFR Part 820), which has been in place since 1996.
Key objectives of QMSR:
1. International Harmonization
- Align FDA requirements with ISO 13485:2016
- Reduce regulatory burden for global manufacturers
- Facilitate international trade and mutual recognition
- Support Medical Device Single Audit Program (MDSAP)
2. Modernization of Quality Requirements
- Incorporate risk-based approaches
- Update terminology and requirements for modern manufacturing
- Include software and digital health considerations
- Enhance supply chain and cybersecurity controls
3. Streamlined Compliance
- Single QMS for global markets
- Reduced duplicate inspections
- Clearer regulatory expectations
- Improved consistency with EU MDR requirements
Major changes from QSR to QMSR:
Risk Management Integration - QMSR explicitly requires risk management throughout the product lifecycle, aligned with ISO 14971. QSR only implicitly addresses risk.
Design Controls Enhancement - Expanded design and development requirements including design transfer, design changes, and validation activities.
Supply Chain Management - Strengthened supplier controls and outsourced process management requirements.
Management Responsibility - Enhanced management review requirements and resource management provisions.
Post-Market Surveillance - Stronger emphasis on post-market activities including complaint handling, adverse event reporting, and corrective actions.
Documentation Requirements - Modernized documentation standards allowing for electronic quality management systems and digital records.
Implementation timeline and transition:
The FDA released the proposed QMSR rule in February 2022. Once finalized, manufacturers will have a transition period (likely 3-5 years) to update their QMS to comply with the new requirements. During the transition, manufacturers may choose to comply with either QSR or QMSR.
Benefits for manufacturers:
- Single QMS for US, EU, and other markets accepting ISO 13485
- Reduced compliance costs through harmonization
- Improved product quality through modern risk-based approaches
- Enhanced global market access
- Alignment with industry best practices
Preparation recommendations:
1. Review current QMS against ISO 13485:2016 requirements
2. Identify gaps between existing QSR compliance and QMSR expectations
3. Develop transition plan and timeline
4. Train quality personnel on new requirements
5. Update documentation and procedures
6. Consider early adoption to gain competitive advantage
Related Terms
More Compliance & Standards
View all미국 의료기기 제조업체에 대한 현행 우수 제조 관리 기준(cGMP) 요구사항을 규정하는 FDA의 품질 시스템 규정(QSR).
품질 활동 및 결과가 계획된 약정을 준수하는지 여부와 이러한 약정이 효과적으로 구현되고 있는지 확인하기 위한 품질 관리 시스템의 체계적이고 독립적인 검사.
의료기기 제조 및 운영에서 품질 문제를 조사, 시정 및 예방하기 위한 체계적인 접근 방식.
유럽경제지역에서 판매되는 의료기기에 필수인 적합성 표시로, EU 보건, 안전 및 환경 요건 준수를 나타냄.
Need Help with USA Registration?
Pure Global provides regulatory consulting and AI-powered tools to help medical device companies navigate USA market access.

